Esperion Therapeutics Inc
ESPR
$3.18+0.00%
Delayed · as of Sep 8, 2026, 1:17 PM ET
Mkt cap
$816.89M
EV/Sales
1.61
P/E ratio
N/A
FY2025 Revenue
$403.13M
EPS (9mo ended 2025-09-30)
$-0.43
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-5.63%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ESPR revenue for 2025-12-31 was $403.1M. Net income was -$22.7M. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. ESPR currently screens at market cap $816.9M.
Use this ESPR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ESPR income, balance, and cash tables.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Esperion Therapeutics Inc (ESPR) revenue for Dec 31, 2025 was $403.1M. Net income was -$22.7M. Statements: https://lician.com/financials/espr
Esperion Therapeutics Inc (ESPR) market capitalization is $816.9M on the latest cached snapshot.
Esperion Therapeutics Inc (ESPR) cached previous close $3.18; day range $3.18 – $3.19; volume 59,090,465. Session quote: https://lician.com/quote/espr
Esperion Therapeutics Inc (ESPR) latest cached earnings event is "ESPR earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ESPR filing is 8-K · Jul 13, 2026. Filings: https://lician.com/sec/espr